Dianas Dream

Description

ELASTIC PROTEIN POLYPEPTIDE NECK CREAM is formulated for the care of delicate neck skin. The product contains a blend of active ingredients, including hydrolyzed elastic, hydrolyzed arginine, and hydrolyzed collagen, which contribute to its moisturizing and skin-tightening properties. Additional components such as cyclohexasiloxane, oxyethanol, and various extracts, including Panax ginseng root and Delesseria sanguinea, enhance the formulation's efficacy. The cream is enriched with vitamin E, promoting hydration, smoothness, and firmness of the skin. The product is presented in a cream dosage form, with a net weight of 1.76 oz (50 g).

Uses and Indications

This product is indicated for use on delicate neck skin. It is formulated with a rich blend of vitamins and moisturizing peptides, providing lifting, firming, and moisturizing effects. The product aids in tightening the neck skin, resulting in a smooth and firm appearance.

There are no teratogenic or nonteratogenic effects associated with this product.

Dosage and Administration

The recommended dosage is 2 grams administered as a single dose. The specific route and method of administration have not been provided. Healthcare professionals should ensure that the administration technique is appropriate for the patient's condition and in accordance with standard medical practices.

Contraindications

Use of this product is contraindicated for individuals with known allergies to any of its components. It is intended for external use only; therefore, a skin test should be performed prior to application. If an allergic reaction occurs, discontinue use immediately and seek medical attention. Additionally, this product should be kept out of reach of children to prevent accidental ingestion or misuse.

Warnings and Precautions

For external use only, this product necessitates a skin test prior to application. Healthcare professionals should advise patients to discontinue use immediately and seek medical attention if any allergic reactions occur. It is imperative to keep this product out of reach of children to prevent accidental ingestion or misuse.

In addition to the aforementioned warnings, it is essential to reiterate the importance of conducting a skin test before initial use. Should an allergic reaction manifest, patients must be instructed to cease use and consult a healthcare provider for further evaluation and management.

Currently, there are no specific laboratory tests recommended for monitoring the safe use of this product. However, vigilance in observing for signs of allergic reactions is crucial, and patients should be encouraged to report any adverse effects promptly.

Side Effects

Patients should be aware that the product is intended for external use only. Prior to application, it is recommended that a skin test be performed to assess for potential allergic reactions. In the event that an allergic reaction occurs, patients are advised to discontinue use immediately and seek medical attention.

Additionally, it is crucial to keep the product out of reach of children to prevent accidental ingestion or misuse. These precautions are essential to ensure the safety and well-being of all users.

Drug Interactions

There are no specific drug interactions reported for this medication. Additionally, no laboratory test interactions have been identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Dianas Dream (elastic protein polypeptide). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients require adult supervision when using this medication. In cases where body temperature exceeds 39°C, it is advised to seek medical advice promptly.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The product has not been specifically evaluated for use during pregnancy. Currently, there are no explicit statements regarding contraindications or risks to the fetus mentioned in the prescribing information. Additionally, no dosage modifications for pregnant individuals are provided, and there are no special precautions regarding use during pregnancy indicated. Healthcare professionals should consider the lack of specific data when prescribing this product to pregnant patients and weigh the potential benefits against any unknown risks.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any signs of adverse effects or symptoms that may arise. In the absence of specific overdosage data, it is recommended to follow standard medical protocols for managing suspected overdose situations, which may include supportive care and symptomatic treatment as necessary.

In the event of an overdose, healthcare providers should assess the patient's clinical status and consider contacting a poison control center for guidance on management strategies. It is essential to document any observed symptoms and interventions undertaken during the management of the patient.

Nonclinical Toxicology

No relevant information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no pertinent data concerning nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No specific postmarketing experience details are available in the insert text. As such, there are no additional adverse events or rare case reports to summarize at this time.

Patient Counseling

Healthcare providers should advise patients on the proper storage of the medication, emphasizing the importance of keeping it at room temperature, away from sunlight, and out of reach of children to ensure safety and efficacy.

Patients must be informed that the product is for external use only. It is essential to perform a skin test prior to initial use. Should any allergic reaction occur, patients should discontinue use immediately and seek medical attention. Additionally, healthcare providers should remind patients to keep the product out of reach of children to prevent accidental ingestion or misuse.

When the medication is to be used on children, healthcare providers should stress the necessity of adult supervision during application. Furthermore, if a child's body temperature exceeds 39°C, patients should be advised to seek medical advice promptly to ensure appropriate care and management.

Storage and Handling

The product is supplied in packaging that ensures its integrity and safety. It should be stored at room temperature, away from direct sunlight, to maintain its efficacy. Additionally, it is essential to keep the product out of reach of children to prevent accidental ingestion or misuse. Proper handling and storage conditions are crucial for preserving the quality of the product.

Additional Clinical Information

The product is intended for cutaneous administration. Patients should apply an appropriate amount evenly on the neck, gently massaging it with fingertips until fully absorbed, and use it twice daily, in the morning and evening.

Clinicians should counsel patients that the product is for external use only and recommend performing a skin test prior to use. If an allergic reaction occurs, patients should discontinue use and seek medical attention. It is important to keep the product out of reach of children, and adult supervision is required when used on children. Additionally, if a child's body temperature exceeds 39°C, medical advice should be sought.

Drug Information (PDF)

This file contains official product information for Dianas Dream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)